Endothelial Dysfunction in Hyperemesis Gravidarum
1 other identifier
observational
50
1 country
1
Brief Summary
The purpose of the study is to determine serum inflammatory adhesion molecules levels in hyperemesis gravidarum
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2016
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2016
CompletedFirst Submitted
Initial submission to the registry
December 8, 2016
CompletedFirst Posted
Study publicly available on registry
December 12, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2017
CompletedDecember 12, 2016
December 1, 2016
3 months
December 8, 2016
December 8, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Serum inflammatory adhesion molecules in hyperemesis gravidarum
4 months
Study Arms (2)
hyperemesis gravidarum with dehydration
The first group was formed of the patients diagnosed hyperemesis gravidarum with dehydration
Control group
The control group was formed of the patients who were healthy pregnant women admitted to the clinic just for routine examination without any symptoms
Eligibility Criteria
The study population consisted of 2 groups; (1) the hyperemesis gravidarum group, consist of 25 pregnant women who developed dehydration due to HG between 6 and 13 gestational weeks and between 18 and 35 years (2) the normal pregnancy group, consisting of 25 pregnant women.
You may qualify if:
- gestational weeks
- between 18-35 years of age
- Single pregnancy
- Dehydration due to HG
You may not qualify if:
- Other pathologies causing nausea and vomiting;
- gastroenteritis
- gastroparesis
- gall duct diseases
- hepatitis
- peptic ulcers
- appendicitis
- pyelonephritis
- urinary tract stones
- hyperthyroidism
- hyperparathyroidism
- migraine
- vestibular diseases
- Patients were excluded from the study in the presence of parameters that may cause endothelial dysfunction such as;
- pregestational diabetes
- +11 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kayseri Training and Research Hospital
Kayseri, 38000, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Erdem SAHİN
Kayseri Training and Research Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 8, 2016
First Posted
December 12, 2016
Study Start
December 1, 2016
Primary Completion
March 1, 2017
Study Completion
March 1, 2017
Last Updated
December 12, 2016
Record last verified: 2016-12